| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Jan 17, 2024 | BioCorRx Inc. | President | Buy | 67.5 | +3,126 | 0.66% | ✗ | $2.2K |
| Apr 3, 2023 | Apr 5, 2023 | BioCorRx Inc. | Director | Buy | 97.5 | +354,902 | 93.09% | ✗ | $299.8K |
| Jan 30, 2023 | Jan 31, 2023 | BioCorRx Inc. | Director | Buy | 60.0 | +400 | 0.39% | ✗ | $554 |
| Jan 26, 2023 | Jan 27, 2023 | BioCorRx Inc. | Director | Buy | 60.0 | +500 | 0.49% | ✗ | $646.5 |
| Jan 24, 2023 | Jan 25, 2023 | BioCorRx Inc. | Director | Buy | 55.0 | +200 | 0.20% | ✗ | $240 |
| Jan 13, 2023 | Jan 17, 2023 | BioCorRx Inc. | Director | Buy | 82.5 | +4,000 | 4.12% | ✗ | $4.5K |
| Dec 30, 2022 | Jan 4, 2023 | BioCorRx Inc. | Director | Buy | 85.0 | +7,634 | 8.54% | ✗ | $2.5K |
| Dec 12, 2022 | Dec 15, 2022 | BioCorRx Inc. | Director | Buy | 85.0 | +5,000 | 5.92% | ✗ | $4.2K |
| Sep 6, 2022 | Oct 11, 2022 | BioCorRx Inc. | Director | Buy | 77.5 | +1,590 | 1.92% | ✗ | $3.1K |
| Aug 29, 2022 | Aug 31, 2022 | BioCorRx Inc. | Director | Buy | 85.0 | +3,878 | 5.07% | ✗ | $8.2K |
| Aug 25, 2022 | Aug 29, 2022 | BioCorRx Inc. | Director | Buy | 77.5 | +1,060 | 1.40% | ✗ | $2.3K |
| Sep 30, 2021 | Oct 25, 2021 | BioCorRx Inc. | Director | Buy | 77.5 | +2,931 | 2.15% | ✗ | $5K |
| Jan 22, 2021 | Mar 2, 2021 | BioCorRx Inc. | Director | Buy | 100.0 | +564,500 | 215.76% | ✗ | $1.1M |
| Apr 3, 2019 | Apr 4, 2019 | BioCorRx Inc. | Director | Buy | 100.0 | +200,000 | 440.42% | ✗ | $3M |
| Sep 6, 2013 | Sep 6, 2013 | DoubleLine Income Solutions Fund | Secretary | Buy | 95.0 | +7,325 | 100.00% | ✗ | $150.2K |